FDA launches competition to spur innovative technologies to help reduce opioid overdose deaths

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: FDA launches competition to spur innovative technologies to help reduce opioid overdose deaths

View as webpage 

News Release

For Immediate Release: Sept. 19, 2016
Media Inquiries: Michael Felberbaum, 240-402-9548, michael.felberbaum@xxxxxxxxxxx
Consumer Inquiries: 888-INFO-FDA

FDA launches competition to spur innovative technologies to help reduce opioid overdose deaths

Contest seeks to stimulate development of a mobile app to connect those experiencing an overdose with the potentially life-saving antidote

The U.S. Food and Drug Administration today announced the 2016 Naloxone App Competition, a public contest focused on developing innovative technologies to combat the rising epidemic of opioid overdose. 

Read more. 

###

---

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency is also responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

---

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)